300+ investors in your industry, stage, and region Get
Any industry
Artificial Intelligence
Google
EdTech
Clean Energy
Retail
Enterprise Software
Local
Travel
Platforms
InsurTech
Oil and Gas
Cryptocurrency
Social Impact
SaaS
Film
Restaurants
Photography
Payments
Renewable Energy
Organic Food
Email
Fitness
CleanTech
Energy
Health Care
Machine Learning
Agriculture (AgTech)
Marketplace
Gaming
Social Network
Facebook
Blockchain
B2B
Big Data
Video Games
Education
Wellness
Medical Device
Mobile
Legal
Sports
Construction
Automotive
eSports
Hospitality
Biotechnology
Consumer
Software
Crowdfunding
Web3
Medical
Theatre
Recruiting
Venture Capital
Social
Infrastructure
Fashion
Beauty
LGBT
Celebrity
Cannabis
Climate
Mobile Apps
Life Science
Publishing
Food and Beverage
Wine and Spirits
Real Estate
Sporting Goods
Art
Music
Finance
Digital Media
FinTech
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Mobile Advertising
Internet
Android
Impact
Biotech
Proptech
Sustainability
Hardware
Transportation
Enterprise
Community
Media (Entertainment)
Any country
South Korea
Africa
Oceania
Brazil
Saudi Arabia
Singapore
LATAM
Greece
Gibraltar
Norway
Liberia
Mexico
Taiwan
Sweden
Zambia
Puerto Rico
Nigeria
Isle of Man
Tunisia
Pakistan
Romania
Russian Federation
Togo
Tajikistan
Zimbabwe
Oman
Colombia
Cameroon
Australia
India
New Zealand
China
Sri Lanka
Vietnam
Armenia
Costa Rica
Chile
Switzerland
Czech Republic
Kenya
Cayman Islands
Kuwait
Kazakhstan
Jamaica
Marshall Islands
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uganda
Turkey
Uzbekistan
Venezuela
Guatemala
Seychelles
Japan
Germany
United Kingdom
Canada
Ireland
South Africa
Egypt
France
Georgia
Denmark
Croatia
Hong Kong
Ghana
Iraq
Mali
Morocco
Myanmar
Latvia
Malaysia
Portugal
Philippines
Poland
Rwanda
Sierra Leone
Senegal
Thailand
El Salvador
Uruguay
Tanzania
United States
Indonesia
Middle East
Bermuda
Dominican Republic
Asia
Albania
Cyprus
Qatar
United Arab Emirates
Spain
Angola
Europe
Argentina
Bangladesh
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Bulgaria
Ecuador
Bahrain
Bahamas
Estonia
Faroe Islands
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Grenada
Israel
Honduras
Iceland
Cambodia
Lithuania
Liechtenstein
Lebanon
Mongolia
Slovenia
Peru
San Marino
Ukraine
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 10 Biotech Angel Investors in Australia (June 2026)

The most active angel investors investing in Australia Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Australia Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Allan Moss
Angel
2 Australia, United States, The Netherlands Series A, Seed Health Care, Medical Device, Biotechnology $2.4M–$8.8M
Mike Wallas
Angel
2 Australia Seed Video, Water, Biotechnology
Anton Borzov
Angel
1 United States, Estonia, Ukraine Seed, Pre-Seed, Series A Information Technology, Artificial Intelligence, Medical $500k–$2.6M
Carl Stubbings
Angel
1 Australia Seed Medical, Health Care, Biotechnology
Richard Lipscombe
Angel
1 Australia Seed Medical, Health Care, Biotechnology
Artesian Investment
Angel
1 United States, India, Australia Pre-Seed, Seed, Series A Artificial Intelligence, Agriculture, Information Technology
Annie Hill
Angel
1 Australia Seed Aquaculture, Life Science, Biotechnology
Catherine Lacavera
Angel
1 Canada, Australia, United States Seed, Pre-Seed Medical, Robotics, Health Care
Daniel Petre
Angel
1 Australia, Canada Seed, Series A, Series B SaaS, Software, Health Care $740k–$11M
Stephen Ho
Angel
1 Australia Seed Medical, Health Care, Biotechnology
Access all 17 angel investors in Australia Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Allan Moss
Angel · Sydney, New South Wales, Australia · 2 investments in Australia Biotech startups

Allan Moss acts an adviser to Anchorage’s Investment Committee. Currently Principal of Allan Moss Investments, a private investment company, Allan retired from the role of Managing Director and Chief Executive Officer of Macquarie Group in May 2008. He was with Macquarie Group for 31 years and served as CEO from 1993 to his retirement in2008. He was also a non- executive director of CSR Ltd from 1996 to 2001.Allan graduated from Sydney University in Arts with a major in Economics and in Laws with Honours. He is also a graduate of Harvard University with a Masters Degree in Business Administration with High Distinction. Allan has received numerous industry awards and recognitions. He was twice named by Barron’s Magazine as one of the 30 most respected CEOs in the world (2006, 2007). He was appointed an Officer of the Order of Australia in 2005.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Series A, Seed
  • Geography: Australia, United States, The Netherlands

Investor stats

  • Total investments: 9
  • Round size: Series A $2.4M–$8.8M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Skykraft — Skykraft is an Australian space services firm that specializes in smallsat constellation design, production, and operation.
  • Ferronova — Ferronova is a medical device company that offers imaging and surgery products.
  • Invert Robotics — Invert Robotics develops robotic NDT inspection technologies for the maintenance of industrial equipment in the food and beverage, pharmaceutical, and oil and gas industries. Invert Robotics highly skilled team of engineers have developed a world leading modular inspection platform suitable for use across a range of industries and applications.
Show all investments...

Mike Wallas
Angel · Brisbane, Queensland, Australia · 2 investments in Australia Biotech startups

Mike Wallas - Advisory Board @ Optifire Pty Ltd

Show more...

Investment focus

  • Industry: Video, Water, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PERKii — PERKii Targeted Release Probiotics are naturally micro-shielded to resist stomach acid up to 10,000x stronger than non micro-shield probiotics. For a targeted release in your gut and a difference you can feel. PERKii Probiotic Drinks are bottled with one billion or more probiotics per serve.
  • Clipchamp — Create videos with royalty-free music and stock footage, use video templates, and export in up to 4K video resolution. Get started in-browser or download the Windows app.
Show all investments...

Anton Borzov
Angel · Palo Alto, California, United States · 1 investments in Australia Biotech startups

Anton Borzov is the Product Designer at Neeva.

Show more...

Investment focus

  • Industry: Information Technology, Artificial Intelligence, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Estonia, Ukraine

Investor stats

  • Total investments: 7
  • Round size: Seed $500k–$2.6M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • 3DLOOK — 3DLOOK is an AI-powered technology company, specializing in mobile body scanning and visualization for a diverse set of industries.
  • Cargofy — Cargofy it's a mobile assistant, kind of a "Siri" but for truck drivers. We help truckers access to high paying loads through our app, and receive discounts on fuel, maintenance, and truck parts.
  • Puma Browser — Puma is a mobile browser and wallet for the Web3 ecosystem. Private by design. Today, we enable seamless payments for creators, app & game developers via Coil and ILP protocol and access to HNS & ENS domains. Long term, our goal is to give 1b people access to Web3 world, DeFi, the peer to peer and ownership based economy.
Show all investments...

Carl Stubbings
Angel · 1 investments in Australia Biotech startups

Carl Stubbings is the Chief Commercial Officer at Genetic Technologies Limited.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Show all investments...

Richard Lipscombe
Angel · Perth, Western Australia, Australia · 1 investments in Australia Biotech startups

Richard, a co-founder of the Company, is a highly practised business manager and protein chemist expert in analysing bio-molecules using proteomics techniques. He has an extensive expertise in chemistry, immunology, mass spectrometry, peptide synthesis, high performance computing and robotics.Richard has international experience in both scienceand business gained over a 29-year period in Australia, USA and the UK, including work in hospital and academic laboratories and commercial organisations. He completed his chemistry degree (MA) at Oxford University, his PhD in immunology at London University and was a Post-Doctoral scientist (molecular immunology) in a large research institution in Australia (Telethon Institute for Child Health Research).

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Show all investments...

Artesian Investment
Angel · 1 investments in Australia Biotech startups

Artesian Investment

Show more...

Investment focus

  • Industry: Artificial Intelligence, Agriculture, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, India, Australia

Investor stats

  • Total investments: 9
  • Lead/follow: no public data

Portfolio highlights

  • Nutromics — Nutromics is a MedTech company revolutionising healthcare through continuous real time molecular monitoring. Our Smart Patch biosensor platform will solve some of the biggest healthcare challenges we face today in the fields of chronic disease prevention, chronic disease management, acute diseases and Therapeutic Drug Monitoring.
  • LYRO Robotics — A robotic packing solution for fruits and vegetables
  • HUVIAiR Technologies — A full-stack construction management tool designed for executive leadership. Deliver projects faster, improve build quality and reduce project costs.
Show all investments...

Annie Hill
Angel · 1 investments in Australia Biotech startups

Annie Hill

Show more...

Investment focus

  • Industry: Aquaculture, Life Science, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Fremantle Seaweed — Fremantle Seaweed is growing native seaweed types at a trial farm south of Gage Roads.
Show all investments...

Catherine Lacavera
Angel · Mountain View, California, United States · 1 investments in Australia Biotech startups

Catherine Lacavera is based out of Mountain View, California and is the Chief Legal Officer of Turing and Board of Directors at Toborlife AI. Catherine previously worked at ShipBob as Chief Legal Officer. Catherine Lacavera attended the University of Toronto. Catherine Lacavera has been awarded the Vanguard Award.

Show more...

Investment focus

  • Industry: Medical, Robotics, Health Care
  • Stage:Seed, Pre-Seed
  • Geography: Canada, Australia, United States

Investor stats

  • Total investments: 3
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Skritswap — skritswap has AI technology that enables anyone to understand anything regardless of complexity.
  • HealthMatch — HealthMatch is a medical technology company that applies machine learning and artificial intelligence to clinical data to save lives.We aim to dramatically accelerate patient recruitment to clinical trials, and progress life-saving cures onto the market faster than existing practices allow.For clinicians and patients, there is a real struggleto identify and find appropriate trials, particularly where the criteria relating to each trial is inconsistently articulated. HealthMatch encodes qualifying questions relating to each patients condition. The platform matches responses to its trial dataset, and confirms only the correct-match trials for that patient — thereby streamlining the identification of suitable trials and facilitating a patient’s application to those trials.With Ai and software at the core, HealthMatch delivers a radically simple product to match patients with drug trials, backed by an execution approach to data that is deceptively complex to achieve and replicate. In doing so, HealthMatch is dramatically changing an industry that has essentially not moved beyond telephones and excel spreadsheets.
  • Toborlife AI — Toborlife AI creates self-governing robot control systems. We collaborate with Unitree to provide high-performing, reasonably priced robotic systems for both commercial and residential clients.
Show all investments...

Daniel Petre
Angel · Sydney, New South Wales, Australia · 1 investments in Australia Biotech startups

Daniel Petre is the Founder of StartGiving. He was a Founding Chairman and Board Member at Ninemsn. He attended the University of Sydney.

Show more...

Investment focus

  • Industry: SaaS, Software, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Australia, Canada

Investor stats

  • Total investments: 8
  • Round size: Seed $740k–$808k; Series A $6.5M–$11M; Series B $5M–$8.8M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Ento — Ento was founded in Australia in 2009 and provides one platform for HR, WFM and engagement. Since then we’ve become the chosen solution for over 3,000 workplaces across retail, hospitality, health, community, and more; rostering more than 30 million shifts for businesses ranging in size from 10 to 2,000+ staff.Our software is part of the nextgeneration of workforce management tools; cloud-based, accessible via a smartphone, tablet or desktop, and integrated with leading ATS, POS and payroll systems to provide a complete solution.
  • Xylo Bio — Psylo is an Australia-based psychedelic biotech business focusing on Psychedelic-inspired medicine to treat mental illness.
  • Kismet — Find the best disability or healthcare service to support your journey
Show all investments...

Stephen Ho
Angel · 1 investments in Australia Biotech startups

Stephen Ho

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Australia

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Diag-Nose.io — Antibiotic resistance is rising to dangerously high levels in all parts of the world threatening our ability to treat common infectious diseases. Diag-Nose is working on a novel diagnostic tool to non-invasively distinguish between viral,bacterial and allergy-mediated sinusitis.
Show all investments...

Biotech Angel investor funding in Australia at a glance

Stats across 15 deals from 17 investors.

17
investors
in Australia Biotech startups
15
deals
in Australia Biotech startups
$4M
median round
in Australia Biotech startups
12%
lead investors
lead at least one round
27%
Seed
most common funding stage

Access all 17 angel investors in Australia Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in Australia investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 17 angel investors investing in Australia Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists